News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
US Approves Pfizer Inc. Generic of Novartis AG Genotropin
September 3, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ZURICH, Sept 3 (Reuters) - U.S. regulators approved Novartis AG's Omnitrope Pen 10 with liquid cartridge, a copy-cat version of Pfizer Inc's human growth hormone Genotropin.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Europe
Pfizer
Novartis
MORE ON THIS TOPIC
Complete response letters
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag
January 8, 2026
·
2 min read
·
Dan Samorodnitsky
Podcast
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
January 7, 2026
·
2 min read
·
Heather McKenzie
Multiple sclerosis
Sanofi’s MS Drug Tripped Up by Toxicities, Unclear Benefit, Rejection Letter Reveals
January 6, 2026
·
3 min read
·
Tristan Manalac
FDA
FDA Went Against Adcomm Votes More, Held Fewer Meetings in 2025
January 6, 2026
·
3 min read
·
Heather McKenzie
